Global Neuroendocrine Tumors Therapeutics Market 2019-2023

Below are some of the key findings from this neuroendocrine tumors therapeutics market analysis report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now! 

Global neuroendocrine tumors therapeutics industry overview

Increasing research grants and funding will have a significant impact on the growth of the global neuroendocrine tumors therapeutics market in the coming years. Several organizations and companies are focusing on providing fundings and grants for the treatment of neuroendocrine tumors as it might turn fatal if left untreated. Moreover, growing research grants and funding also help in strengthening the neuroendocrine tumors therapeutics development pipeline. The Neuroendocrine Tumor Research Foundation has already announced an investment of USD 4 million as collaborative grants for neuroendocrine tumor research. Such funding programs help in better and quick development of neuroendocrine tumors therapeutics, encouraging patients to avail the treatment, hence boosting the market growth.

Moreover, the growing awareness of neuroendocrine tumors will also drive global market growth. To create awareness about neuroendocrine tumors and for the early diagnosis of the disease, several organizations are conducting national and international programs. For instance, the International Neuroendocrine Cancer Alliance observes neuroendocrine tumor cancer day every year, and the annual event is aimed at raising awareness about all types of neuroendocrine tumors. Additionally, the event also provides a platform for addressing challenges faced by healthcare practitioners and patients. In addition to benefitting healthcare practitioners, these programs also help vendors by providing future research opportunities. Such factors will have a positive impact on the growth of the neuroendocrine tumors therapeutics market, which will register a CAGR of close to 9% during the forecast period.

Top neuroendocrine tumors therapeutics companies covered in this report

The global neuroendocrine tumors therapeutics market is highly concentrated. Because of the high investment required for drug development and commercialization, vendors are focusing on entering into partnerships with other companies. To help clients improve their revenue share, this research report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. Key insights provided by this neuroendocrine tumors therapeutics market analysis report will help companies make informed business decisions.

The report offers a detailed analysis of several leading neuroendocrine tumors therapeutics companies, including:

• F. Hoffmann-La Roche Ltd
• Ipsen Pharma
• Merck & Co., Inc
• Novartis AG
• Pfizer Inc.

Neuroendocrine tumors therapeutics market segmentation based on the type

• Somatostatin analogs
• Targeted therapies
• Other therapies

Somatostatin analogs market segment held the largest neuroendocrine tumors therapeutics market share in 2018 because of their unique mechanism and ability to control the size and growth of tumor within the body. The segment will account for the largest market share throughout the forecast period.

Neuroendocrine tumors therapeutics market segmentation based on region

• Asia
• Europe
• North America
• ROW

North America accounted for the largest neuroendocrine tumors therapeutics market share in 2018 because of the increasing incidence of the condition in the region. Though North America’s contribution to the growth of the neuroendocrine tumors therapeutics market size will decrease in the coming years, the region will account for the largest neuroendocrine tumors therapeutics market share throughout the forecast period.

Key highlights of the global neuroendocrine tumors therapeutics market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the neuroendocrine tumors therapeutics market during the next five years
• Precise estimation of the global neuroendocrine tumors therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the neuroendocrine tumors therapeutics industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on several vendors
• Comprehensive details on factors that will challenge the growth of neuroendocrine tumors therapeutics companies 

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch